[go: up one dir, main page]

IL144827A0 - Soluble double metal salts of hydroxycitric acid, processes for the preparation thereof and beverages containing the same - Google Patents

Soluble double metal salts of hydroxycitric acid, processes for the preparation thereof and beverages containing the same

Info

Publication number
IL144827A0
IL144827A0 IL14482799A IL14482799A IL144827A0 IL 144827 A0 IL144827 A0 IL 144827A0 IL 14482799 A IL14482799 A IL 14482799A IL 14482799 A IL14482799 A IL 14482799A IL 144827 A0 IL144827 A0 IL 144827A0
Authority
IL
Israel
Prior art keywords
processes
preparation
same
metal salts
double metal
Prior art date
Application number
IL14482799A
Original Assignee
Vittal Mallya Scient Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vittal Mallya Scient Res Found filed Critical Vittal Mallya Scient Res Found
Publication of IL144827A0 publication Critical patent/IL144827A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • C07C51/44—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/48—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14482799A 1999-02-18 1999-02-18 Soluble double metal salts of hydroxycitric acid, processes for the preparation thereof and beverages containing the same IL144827A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN1999/000004 WO2000048983A1 (en) 1999-02-18 1999-02-18 Soluble double metal salt of group ia and iia of (-) hydroxycitric acid

Publications (1)

Publication Number Publication Date
IL144827A0 true IL144827A0 (en) 2002-06-30

Family

ID=11076651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14482799A IL144827A0 (en) 1999-02-18 1999-02-18 Soluble double metal salts of hydroxycitric acid, processes for the preparation thereof and beverages containing the same

Country Status (6)

Country Link
EP (1) EP1154978A1 (en)
JP (1) JP2002542152A (en)
AU (1) AU2851799A (en)
CA (1) CA2364245C (en)
IL (1) IL144827A0 (en)
WO (1) WO2000048983A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001527022A (en) 1997-07-14 2001-12-25 ラジュ、ジー・ガンガ Hydroxycitric acid compositions, supplements and supplements and foods made therefrom and methods of using them in reducing body weight
US7119110B2 (en) 2001-10-05 2006-10-10 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
US20030119913A1 (en) 2001-12-20 2003-06-26 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
US6875891B2 (en) * 2003-05-12 2005-04-05 Laila Impex Process for preparing highly water soluble double salts of hydroxycitric acid particularly alkali and alkaline earth metal double salts
CN1878543A (en) * 2003-09-11 2006-12-13 格利康科技集团有限责任公司 Enteric delivery of (-)-hydroxycitric acid
WO2008099413A2 (en) * 2007-02-16 2008-08-21 Vittal Mallya Scientific Research Foundation High purity (-) hydroxycitric acid metal salt derivatives and method of preparation of the same
JP2011079752A (en) * 2009-10-05 2011-04-21 Kracie Home Products Ltd Pancreatic lipase inhibitor, food and beverage composition containing the same and pharmaceutical composition
WO2018049216A1 (en) 2016-09-08 2018-03-15 Glykon Technologies Group, Llc Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536630A (en) * 1968-05-21 1970-10-27 Us Agriculture Calcium sequestration in highly alkaline medium
US5536516A (en) * 1994-08-24 1996-07-16 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and food products prepared therefrom
AU5736096A (en) * 1995-05-15 1996-11-29 Sabinsa Corporation A new process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy cit ric acid

Also Published As

Publication number Publication date
JP2002542152A (en) 2002-12-10
CA2364245A1 (en) 2000-08-24
EP1154978A1 (en) 2001-11-21
AU2851799A (en) 2000-09-04
CA2364245C (en) 2010-10-05
WO2000048983A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
HUP0401647A3 (en) Novel betha-phenyl-alpha-oxy propionic acid derivatives, processes for their preparation and their use in the preparation of pharmaceutically important compounds
IL138969A0 (en) Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0200807A3 (en) Substituted propionic acid derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201633A3 (en) Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0105437A3 (en) Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
IL145732A0 (en) α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
HUP0201730A3 (en) Thienopyrimidines as phosphodiesterase inhibitors, their use, pharmaceutical compositions containing them and process for the preparation thereof
HUP0304085A2 (en) The citrate salt of 5,8,14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
WO2001010408A3 (en) Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
IL144827A0 (en) Soluble double metal salts of hydroxycitric acid, processes for the preparation thereof and beverages containing the same
AU2733699A (en) Keto acid salts and amine derivatives, and their use for preparing medicines
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
ZA995597B (en) Process for the preparation of nicotinic acid.
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
AU2002233353A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
AU2001240001A1 (en) Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
HUP0101415A3 (en) 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use
HUP0102124A3 (en) Process for preparing 2-acetylthio-3-phenyl-propionic acid and the salts thereof
ZA200006081B (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-A/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
HUP0200412A3 (en) New morpholinobenzamide salts, process for their preparation and pharmaceutical compositions containing them and their use
HUP0000982A3 (en) Process for the preparation of 1,1-dioxo-penicillanic acid derivatives
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof